Neuropeptide Y: Clinical Trials

2 trials of Neuropeptide Y, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1
Phase 11Unknown 1

Follow Neuropeptide Y: new trials by email Literature Review of Neuropeptide Y trials Research Report on Neuropeptide Y

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder
Neuropeptide Y, Placebo - Stress Disorders, Post-Traumatic, Stress Disorders, Traumatic, Acute
Phase 1 / Phase 2UnknownNew York Medical College1172019-11-012019-08-28
Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers
Low dose NPY, High dose NPY, Placebo - Mood Disorder, Anxiety Disorders
Phase 2CompletedDennis Charney102010-01-012017-08-01

Conditions studied

Anxiety Disorders (2)  ·  Mood Disorders (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Stress Disorders, Traumatic, Acute (1)

Sponsors

Dennis Charney (1)  ·  New York Medical College (1)

Countries

United States (2)

Top investigators

Adriana Feder, MD (1)  ·  Dennis Charney, MD (1)  ·  Esther Sabban, PhD (1)  ·  Rhea Dornbush, PhD (1)  ·  Yvette Smolin, MD (1)

Results publications

PMID 35141873, PMID 38767196